The wire › SEC Form 8-K
NRX Pharmaceuticals, Inc. NRXP
Filed with the SEC on Jan 16, 2026. Reported event date Jan 12, 2026.
- Business address
- Wilmington, DE
- State
- Delaware
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2834)
- SEC CIK
- 1719406
- Accession number
- 0001437749-26-001455
Items reported in this filing
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 7.01 Regulation FD Disclosure
- Item 8.01 Other Events
- Item 9.01 Financial Statements and Exhibits
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing